Fig. 1: Disposition of eyes with MO secondary to BRVO.
aEyes from 3070 patients. bEyes from 1457 patients. BRVO branch retinal vein occlusion, MO macular oedema, VA visual acuity, VEGF vascular endothelial growth factor.
Fig. 1: Disposition of eyes with MO secondary to BRVO. | Eye
